Ads
related to: bristol-myers squibb
Search results
EU regulator mandates label updates on CAR-T cancer therapies
Reuters via AOL· 41 minutes agoThe European Medicines Agency's (EMA) mandate, which echoes the one issued by the U.S. health...
Birchview Capital LP Has $36.04 Million Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)
ETF DAILY NEWS· 1 day agoBirchview Capital LP cut its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 2.0% during the fourth quarter, according to the company in its most recent 13F filing with ...
Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 1 day agoBristol Myers Squibb (BMY) has been one of the most searched-for stocks on Zacks.com lately. So, you...
Bristol Myers Squibb (BMY) Beats Stock Market Upswing: What Investors Need to Know
Zacks via Yahoo Finance· 3 days agoBristol Myers Squibb (BMY) ended the recent trading session at $43.02, demonstrating a +1.06% swing...
Bristol-Myers Squibb Insiders Sold US$1.1m Of Shares Suggesting Hesitancy
Simply Wall St. via Yahoo Finance· 6 days agoOver the past year, many Bristol-Myers Squibb Company (NYSE:BMY) insiders sold a significant stake...
Bristol Myers Squibb to cut 862 NJ workers as part of $1.5B cost-savings plan
NJBIZ· 7 days agoAs part of a larger restructuring effort, Princeton-based pharma giant Bristol Myers Squibb plans to...
Why Bristol Myers Squibb Is A Top Socially Responsible Dividend Stock
Forbes· 4 days agoBristol Myers Squibb has been named a Top Socially Responsible Dividend Stock
Bristol-Myers Squibb's Options Frenzy: What You Need to Know - Bristol-Myers Squibb (NYSE:BMY)
Benzinga· 4 days agoLoading... Loading... Investors with a lot of money to spend have taken a bullish stance on Bristol-Myers Squibb BMY . And retail traders should know. We noticed this today when the trades showed ...
Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb
Digital Journal· 2 days agoPRESS RELEASE Published June 12, 2024 ACCESSWIRE Key scientific achievement advances the joint pipeline in the strategic neuroscience partnership with Bristol Myers Squibb and earns a payment ...
Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
BioPharma Dive via Yahoo Finance· 4 hours agoThe Japanese pharma paid $100 million to secure option rights to an Ascentage drug. Elsewhere, J.P....